BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23770587)

  • 21. Rett Syndrome, a Neurodevelopmental Disorder, Whole-Transcriptome, and Mitochondrial Genome Multiomics Analyses Identify Novel Variations and Disease Pathways.
    Aldosary M; Al-Bakheet A; Al-Dhalaan H; Almass R; Alsagob M; Al-Younes B; AlQuait L; Mustafa OM; Bulbul M; Rahbeeni Z; Alfadhel M; Chedrawi A; Al-Hassnan Z; AlDosari M; Al-Zaidan H; Al-Muhaizea MA; AlSayed MD; Salih MA; AlShammari M; Faiyaz-Ul-Haque M; Chishti MA; Al-Harazi O; Al-Odaib A; Kaya N; Colak D
    OMICS; 2020 Mar; 24(3):160-171. PubMed ID: 32105570
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2.
    Amir RE; Van den Veyver IB; Wan M; Tran CQ; Francke U; Zoghbi HY
    Nat Genet; 1999 Oct; 23(2):185-8. PubMed ID: 10508514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel alterations in the epigenetic signature of MeCP2-targeted promoters in lymphocytes of Rett syndrome patients.
    Lilja T; Wallenborg K; Björkman K; Albåge M; Eriksson M; Lagercrantz H; Rohdin M; Hermanson O
    Epigenetics; 2013 Mar; 8(3):246-51. PubMed ID: 23348913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.
    Gadalla KK; Bailey ME; Cobb SR
    Biochem J; 2011 Oct; 439(1):1-14. PubMed ID: 21916843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacological reactivation of inactive X-linked
    Przanowski P; Wasko U; Zheng Z; Yu J; Sherman R; Zhu LJ; McConnell MJ; Tushir-Singh J; Green MR; Bhatnagar S
    Proc Natl Acad Sci U S A; 2018 Jul; 115(31):7991-7996. PubMed ID: 30012595
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activity-dependent aberrations in gene expression and alternative splicing in a mouse model of Rett syndrome.
    Osenberg S; Karten A; Sun J; Li J; Charkowick S; Felice CA; Kritzer M; Nguyen MVC; Yu P; Ballas N
    Proc Natl Acad Sci U S A; 2018 Jun; 115(23):E5363-E5372. PubMed ID: 29769330
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.
    Jentarra GM; Olfers SL; Rice SG; Srivastava N; Homanics GE; Blue M; Naidu S; Narayanan V
    BMC Neurosci; 2010 Feb; 11():19. PubMed ID: 20163734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2.
    Young JI; Hong EP; Castle JC; Crespo-Barreto J; Bowman AB; Rose MF; Kang D; Richman R; Johnson JM; Berget S; Zoghbi HY
    Proc Natl Acad Sci U S A; 2005 Dec; 102(49):17551-8. PubMed ID: 16251272
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biotin tagging of MeCP2 in mice reveals contextual insights into the Rett syndrome transcriptome.
    Johnson BS; Zhao YT; Fasolino M; Lamonica JM; Kim YJ; Georgakilas G; Wood KH; Bu D; Cui Y; Goffin D; Vahedi G; Kim TH; Zhou Z
    Nat Med; 2017 Oct; 23(10):1203-1214. PubMed ID: 28920956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.
    Kaufmann WE; Johnston MV; Blue ME
    Brain Dev; 2005 Nov; 27 Suppl 1():S77-S87. PubMed ID: 16182491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiplex epigenome editing of
    Qian J; Guan X; Xie B; Xu C; Niu J; Tang X; Li CH; Colecraft HM; Jaenisch R; Liu XS
    Sci Transl Med; 2023 Jan; 15(679):eadd4666. PubMed ID: 36652535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.
    Chen RZ; Akbarian S; Tudor M; Jaenisch R
    Nat Genet; 2001 Mar; 27(3):327-31. PubMed ID: 11242118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome.
    Krishnan N; Krishnan K; Connors CR; Choy MS; Page R; Peti W; Van Aelst L; Shea SD; Tonks NK
    J Clin Invest; 2015 Aug; 125(8):3163-77. PubMed ID: 26214522
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MeCP2 SUMOylation rescues Mecp2-mutant-induced behavioural deficits in a mouse model of Rett syndrome.
    Tai DJ; Liu YC; Hsu WL; Ma YL; Cheng SJ; Liu SY; Lee EH
    Nat Commun; 2016 Feb; 7():10552. PubMed ID: 26842955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MECP2 and CDKL5 gene mutation analysis in Chinese patients with Rett syndrome.
    Li MR; Pan H; Bao XH; Zhang YZ; Wu XR
    J Hum Genet; 2007; 52(1):38-47. PubMed ID: 17089071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reciprocal co-regulation of EGR2 and MECP2 is disrupted in Rett syndrome and autism.
    Swanberg SE; Nagarajan RP; Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2009 Feb; 18(3):525-34. PubMed ID: 19000991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The relationship of Rett syndrome and MECP2 disorders to autism.
    Neul JL
    Dialogues Clin Neurosci; 2012 Sep; 14(3):253-62. PubMed ID: 23226951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of differentiation (ID1, ID2, ID3 and ID4) genes are neuronal targets of MeCP2 that are elevated in Rett syndrome.
    Peddada S; Yasui DH; LaSalle JM
    Hum Mol Genet; 2006 Jun; 15(12):2003-14. PubMed ID: 16682435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Research progress of Rett syndrome causing gene MECP2--the structure, function and modulation of MECP2].
    Zhang JJ; Bao XH
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Dec; 41(6):712-5. PubMed ID: 20019788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. P152R Mutation Within MeCP2 Can Cause Loss of DNA-Binding Selectivity.
    Franklin D
    Interdiscip Sci; 2019 Mar; 11(1):10-20. PubMed ID: 30673959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.